Loading…
Aethlon Medical Inc
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in AEMD.
▼ -100.0% over 5Y.
today you would have $0.41▼ -100.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Year-end price | $6.28 | $13.85 | $344.00 | $876.00 | |
| P/S | — | — | — | — | 43.8x |
| P/B | 1.8x | 2.0x | 0.5x | 2.0x | 1.7x |
| EPS | -$53.05 | -$428.85 | -$1,944.00 | -$2,360.00 | |
| Profit margin | — | — |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| SCNIScinai Immunotherapeutics Ltd. | $2.51 | 0.1x | 0.1x | — | -26.53% | $1.7M |
| BBLGBone Biologics Corp | $0.62 | — | 0.3x | — | -54.96% | $1.69M |
| MNDRMobile-health Network Solutions | $1.55 | — | 0.1x | — | -47.59% | $1.85M |
| DCOYDecoy Therapeutics Inc. | $2.90 |
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.
Company description provided by Yahoo Finance.
| — |
| — |
| -2094.89% |
| ROE | -179.04% | -146.36% | -261.31% | -211.71% | -79.86% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| 0.0x |
| 0.4x |
| — |
| -827.77% |
| $1.9M |
| SXTCChina SXT Pharmaceuticals, Inc. | $3.00 | — | 0.1x | — | -27.49% | $1.6M |
| EDVAEndovia Health Sciences, Inc. | $0.31 | — | — | — | — | $1.99M |